↓ Skip to main content

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes

Overview of attention for article published in PharmacoEconomics, November 2019
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes
Published in
PharmacoEconomics, November 2019
DOI 10.1007/s40273-019-00845-x
Pubmed ID
Authors

Caitlin Smare, Khalid Lakhdari, Justin Doan, John Posnett, Sukhvinder Johal

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 15%
Student > Bachelor 9 11%
Student > Postgraduate 6 8%
Student > Master 5 6%
Student > Ph. D. Student 5 6%
Other 10 13%
Unknown 33 41%
Readers by discipline Count As %
Medicine and Dentistry 13 16%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Economics, Econometrics and Finance 6 8%
Biochemistry, Genetics and Molecular Biology 4 5%
Business, Management and Accounting 2 3%
Other 11 14%
Unknown 37 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2019.
All research outputs
#18,699,437
of 23,175,240 outputs
Outputs from PharmacoEconomics
#1,661
of 1,868 outputs
Outputs of similar age
#335,671
of 457,296 outputs
Outputs of similar age from PharmacoEconomics
#24
of 29 outputs
Altmetric has tracked 23,175,240 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,868 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,296 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.